Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study

Circulation

Volumn 99, Issue 6, 1999, Pages 779-785

  De Lorgeril, Michel ^a,e   Salen, Patricia ^a   Martin, Jean Louis ^b   Monjaud, Isabelle ^a   Delaye, Jacques ^c   Mamelle, Nicole ^d  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b Hospices Civils de Lyon   (France)

^c LOUIS PRADEL HOSPITAL   (France)

^d INSERM   (France)

^e HÔPITAL NORD   (France)

Author keywords

Coronary disease; Diet; Myocardial infarction; Trials

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DRUG USE; FEMALE; FOLLOW UP; GENDER; HEART FAILURE; HEART INFARCTION; HUMAN; LEUKOCYTE COUNT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SECONDARY PREVENTION; SINGLE BLIND PROCEDURE; STROKE; SYSTOLIC BLOOD PRESSURE; UNSTABLE ANGINA PECTORIS;

EID: 0032955055     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.6.779     Document Type: Article

References (30)

1. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2:757-761.
2. Singh RB, Rastogi SS, Verma R, Laxmi B, Singh R, Ghosh S, Niaz MA. Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow-up. BMJ. 1992;304:1015-1019.
3. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343: 1454-1459.
4. de Lorgeril M, Salen P, Monjaud I, Delaye J. The diet heart hypothesis in secondary prevention of coronary heart disease. Eur Heart J. 1997;18: 14-18.
5. Gilman MW, Cupples LA, Gagnon D, Posner BM, Ellison RC, Castelli WP, Wolf PA. Protective effect of fruits and vegetables on development of stroke in men. JAMA. 1995;273:1113-1117.
6. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC. Vegetable, fruit and cereal fiber intake and risk of coronary heart disease among men. JAMA. 1996;275:447-451.
7. Key TJ, Thorogood M, Appleby PN, Burr ML. Dietary habits and mortality in 11000 vegetarians and health conscious people: results of a 17 year follow up. BMJ. 1996;313:775-779.
8. Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC, Ruskin JN, Manson JE. Fish consumption and risk of sudden death. JAMA. 1998;279:23-28.
9. Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P, Walsh MK, Morris D, Shekelle RB. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997;336:1046-1053.
10. 6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary heart disease. Circulation. 1998;97:437-443.
11. Stampfer MJ, Rimm EB. Folate and cardiovascular disease: why we need a trial now. JAMA. 1996;275:1929-1930.
12. Verhaar MC, Wever RM, Kastelein JJ, van Dam T, Koomans A, Rabelink TJ. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation. 1998;97: 237-241.
13. Wever RM, Lüscher TF, Cosentino F, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation. 1998;97: 108-112.
14. de Lorgeril M. Dietary arginine in prevention of cardiovascular diseases. Cardiovasc Res. 1998;37:560-563.
15. de Lorgeril M, Salen P, Martin JL, Mamelle N, Monjaud I, Touboul P, Delaye J. Effect of a Mediterranean-type of diet on the rate of cardiovascular complications in coronary patients: insights into the cardioprotective effect of certain nutriments. J Am Coll Cardiol. 1996;28: 1103-1108.
16. de Lorgeril M, Salen P, Caillat-Vallet E, Monjaud I, Hanauer MT, Mamelle N. Control of bias in dietary trial to prevent coronary recurrences: the Lyon Diet Heart Study. Eur J Clin Nutr. 1997;51:116-122.
17. Zelen M. A new design for randomized clinical trials. N Engl J Med. 1979;300:1242-1245.
18. Yusuf S, Peto R, Lewis JA, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.
19. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92: 1326-1331.
20. Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer M, Willett WC. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ. 1996;313:84-90.
21. Billman GE, Hallaq H, Leaf A. Prevention of ischemia-induced ventricular fibrillation by ω3 fatty acids. Proc Natl Acad Sci U S A. 1994;91: 4417-4430
22. Katan MB. Fish and heart disease. N Engl J Med. 1995;332:1024-1025.
23. Leaf A. Cardiovascular effects of fish oils. Circulation. 1990;82: 624-628.
24. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factors Intervention Trial (MRFIT). JAMA. 1986;256: 2823-2828.
25. Verschuren WMM, Jacobs DR, Bloemberg BPM, Kromhout D, Menotti A, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Nedeljkovic S, Nissinen A, Toshima H. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. JAMA. 1995;274:131-136.
26. Fraser GE, Strahan TM, Sabaté J, Beeson L, Kissinger D. Effect of traditional coronary risk factors on rates of incident coronary events in a low-risk population: the Adventist Health Study. Circulation. 1992;86: 406-413.
27. Kannel WB. Anderson K. Wilson PWF. White blood cell count and cardiovascular disease: insights from the Framingham Study. JAMA. 1992;267:1253-1256.
28. Buja LM, Willerson JT. Role of inflammation in coronary plaque disruption. Circulation. 1994;89:503-505.
29. de Lorgeril M, Basmadjian A, Lavallée M, Clément R, Millette D, Rousseau G, Latour JG. Influence of leukopenia on collateral flow, reperfusion flow, reflow ventricular fibrillation, and infarct size in dogs. Am Heart J. 1989;117:523-532.
30. Kuzuya T, Hoshida S, Suzuki K, Sasaki T, Kitabatake A, Kamada T, Minamino T, Tada M. Polymorphonuclear leukocyte activity and ventricular arrhythmia in acute myocardial infarction. Am J Cardiol. 1988; 62:868-872.